1.Identification of pathogenic variants in three Chinese patients with McCune-Albright syndrome.
Mingchen HAN ; Huan MI ; Xin GUAN ; Xiuzhi REN ; Xiuli ZHAO
Chinese Journal of Medical Genetics 2023;40(2):186-190
OBJECTIVE:
To explore the genetic basis for three Chinese patients with McCune-Albright syndrome (MAS).
METHODS:
Three children who had respectively presented at Shandong Provincial Hospital in April 2019 and Peking Union Medical College Hospital in August 2020 and May 2021 were selected as the research subjects. Peripheral blood samples of the probands and their family members were taken for the extraction of genomic DNA. Potential variants were screened by whole exome sequencing (WES), and candidate variants were validated by Sanger sequencing of the patients and their family members.
RESULTS:
The proband from family 1 was found to harbor a heterozygous c.601C>T (p.R201C) missense variant in exon 8 of the GNAS gene, whilst the probands from families 2 and 3 were both found to harbor a heterozygous c.602G>A (p.R201H) missense variant in exon 8 of the GNAS gene. Both variants were known to be pathogenic, and all probands were found to be mosaics for the corresponding variants but with various degrees.
CONSLUSION
WES can effectively diagnose MAS and other somatic genetic disorders. In this study, the combined WES and Sanger sequencing have verified the degree of mosaicisms of pathogenic variants in the three MAS patients, albeit no apparent correlation was found between the degree of mosaicisms and the phenotype of patients. Above finding has provided a basis for genetic counseling and prenatal diagnosis for the affected families.
Humans
;
Mutation
;
Fibrous Dysplasia, Polyostotic/genetics*
;
East Asian People
;
Exons
;
Phenotype
;
Pedigree
2.Further progress of the etiology,diagnosis and treatment of peripheral precocious puberty.
Chinese Journal of Preventive Medicine 2023;57(6):955-960
Peripheral precocious puberty(PPP),also known as puberty independent from hypothalamic-pituitary axis activation,is stimulated by hormones from other sources, with only partial sexual characteristics development but without mature sexual function. The secondary sexual characteristics development occurs before 7.5 years of age in girls and before 9 years of age in boys. Clinical manifestations are diverse, and PPP has varied etiology including congenital adrenal hyperplasia, McCune-Albright syndrome, ovarian cyst, adrenal tumor, ovarian tumor, testicular tumor, human chorionic gonadotropin producing tumor, familial male precocious puberty, aromatase excess syndrome, and environmental estrogen. Early identification of etiology, accurate differential diagnosis and prenatal gene screening play a significant role in the prevention, diagnosis and treatment of the disease.
Female
;
Humans
;
Male
;
Child
;
Puberty, Precocious/therapy*
;
Fibrous Dysplasia, Polyostotic/complications*
;
Aromatase
4.Clinicopathological analysis of 105 patients with fibrous dysplasia of cranio-maxillofacial region.
Jiang XUE ; Jian Yun ZHANG ; Rui Rui SHI ; Xiao Yan XIE ; Jia Ying BAI ; Tie Jun LI
Journal of Peking University(Health Sciences) 2022;54(1):54-61
OBJECTIVE:
To compare the clinicopathologic features and prognosis of the different types of fibrous dysplasia (FD) of cranio-maxillofacial region, so as to provide a new reference for clinicians to treat these patients and make prognostic judgement.
METHODS:
Clinical records, radiographic data and pathological information of 105 patients diagnosed with FD or McCune-Albright syndrome (MAS) at the Department of Oral Pathology, Peking University Hospital of Stomatology from January 2013 to December 2020 were collected. The patients were divided into 4 groups: monostotic FDs, polyostotic FDs, MAS and a specific type called craniofacial fibrous dysplasia (CFD) limited in the craniofacial region. The clinicopathological characteristics, treatment and follow-up data of each type were analyzed.
RESULTS:
Of all the 105 patients, 46 were males and 59 were females, with a male-to-female ratio of 1 ∶1.3. The onset age ranged from 0 to 56 years and the median age was 12 years. On the basis of different involvement conditions, 4 types were divided. The most common type was monostotic FDs (43 cases, 40.95%), including maxilla (29 cases), mandibular (12 cases) and zygoma (2 cases). 32 cases (30.48%) were diagnosed with polyostotic FDs, 7 cases (6.67%) were MAS, and 23 cases (21.90%) were CFDs confirmed by computed tomography (CT) analysis. CFD was clearly distinct from other types of FD, such as the patient gender and the serum alkaline phosphatase level in peripheral blood before operative surgery. The pathologic findings of various types FD were quite similar, whilst the predominant fibrous tissue hyperplasia could be observed in polyostotic FDs and MAS types.
CONCLUSION
The clinicopathologic features of FD in the cranio-maxillofacial region are different from the FD lesions in other parts of the body. The clinicopathological features of CFD are significantly different from those of monostotic and polyostotic FDs in the cranio-maxillofacial region. Therefore, the clinicians should pay attention to distinguish CFD in clinic, imaging and pathology aspects, so as to further clarify its features in clinic management and prognosis.
Adolescent
;
Adult
;
Child
;
Child, Preschool
;
Female
;
Fibrous Dysplasia, Polyostotic
;
Humans
;
Infant
;
Infant, Newborn
;
Male
;
Mandible
;
Middle Aged
;
Prognosis
;
Tomography, X-Ray Computed
;
Young Adult
5.Copy number alteration profiling facilitates differential diagnosis between ossifying fibroma and fibrous dysplasia of the jaws.
Ming MA ; Lu LIU ; Ruirui SHI ; Jianyun ZHANG ; Xiaotian LI ; Xuefen LI ; Jiaying BAI ; Jianbin WANG ; Yanyi HUANG ; Tiejun LI
International Journal of Oral Science 2021;13(1):21-21
Ossifying fibroma (OF) and fibrous dysplasia (FD) are two fibro-osseous lesions with overlapping clinicopathological features, making diagnosis challenging. In this study, we applied a whole-genome shallow sequencing approach to facilitate differential diagnosis via precise profiling of copy number alterations (CNAs) using minute amounts of DNA extracted from morphologically correlated microdissected tissue samples. Freshly frozen tissue specimens from OF (n = 29) and FD (n = 28) patients were obtained for analysis. Lesion fibrous tissues and surrounding normal tissues were obtained by laser capture microdissection (LCM), with ~30-50 cells (5 000-10 000 µm
DNA Copy Number Variations
;
Diagnosis, Differential
;
Fibroma, Ossifying/genetics*
;
Fibrous Dysplasia of Bone/genetics*
;
Galactosyltransferases
;
Humans
;
Jaw
;
Neoplasm Recurrence, Local
;
Nuclear Proteins
6.Efficacy and safety of letrozole in treatment of McCune-Albright syndrome girls with peripheral precocious puberty.
De XU ; Wenli LU ; Xueqing WANG ; Junqi WANG ; Yiwen XIE ; Zhiya DONG ; Wei WANG
Journal of Zhejiang University. Medical sciences 2020;49(3):291-296
OBJECTIVE:
To evaluate the efficacy and safety of the third-generation aromatase inhibitor letrozole in the treatment of McCune-Albright syndrome (MAS) girls with peripheral precocious puberty.
METHODS:
Twenty-one MAS girls with peripheral precocious puberty treated in Pediatrics Department of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine from March 2012 to June 2017 were enrolled in the study. Patients presented with repeated vaginal bleeding, premature breast enlargement, café-au-lait spots or dysplasia of bone fibers, and low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH); and the congenital adrenal hyperplasia, estrogen-producing tumors, and exogenous estrogen intake were excluded. Letrozole were administrated at a dose of 0.5-2 mg·m ·d for 6 to 12 months. The patients were observed for changes in breast staging, vaginal bleeding, sex hormone levels, liver function and bone age changes, and changes in uterine and ovarian volume.
RESULTS:
After treatment, bone age/chronological age (BA/CA)was decreased from 1.23±0.30 to 1.11±0.18 ( < 0.01); the predicted adult height (PAH) increased from (156.2±5.9)cm to (158.4±2.1)cm after treatment ( < 0.05); the vaginal bleeding was reduced and the estradiol level decreased, while the teststosterone level and the uterus showed no significant increase, and no adverse reactions such as ovarian torsion and abnormal liver function were observed.
CONCLUSIONS
Precocious puberty is one of the most common endocrine manifestations in MAS. Our findings suggest that letrozole may be an effective and safe therapy to precocious puberty in girls with McCune-Albright Syndrome.
Aromatase Inhibitors
;
Child
;
China
;
Female
;
Fibrous Dysplasia, Polyostotic
;
Humans
;
Letrozole
;
Puberty, Precocious
7.Craniofacial Polyostotic Fibrous Dysplasia Initially Diagnosed in a Primary Care Unit.
Korean Journal of Family Medicine 2019;40(1):58-60
Fibrous dysplasia (FD) is a non-malignant bone tumor that typically behaves as a slow and indolent growing mass lesion. We report the case of a female patient presenting with headache and facial deformity and later diagnosed with polyostotic fibrous dysplasia (PFD). A 29-year-old woman visited Mealhada Primary Health Care Unit complaining of headache, nasal congestion, and hyposmia for several weeks. She also presented with facial deformity and painful swelling of the upper left orbit. X-ray imaging revealed a suspicious opacity in the left frontal sinus and a right shift of the nasal septum. Computed tomography and bone scintigraphy later confirmed a tumor involving the ethmoid and frontal bone. The patient was referred to the neurosurgery and otorhinolaryngology departments of a central hospital and the suspected diagnosis of PFD was confirmed. A watchful waiting approach with regular imaging screenings was proposed and accepted by the patient, who is now free of symptoms and more acceptant of the benign condition of her tumor. With this case, we aim to make family physicians more aware of this rare but relevant condition that can be difficult to diagnose. FD is a rare but benign tumor that occurs mainly in adolescents and young adults. Symptoms depend on the location and type of the tumor and include facial deformity, vision changes, nasal congestion, and headache. No clear guidelines exist for its treatment, and options include monitoring the progression of the tumor, in addition to medical or surgical approaches.
Adolescent
;
Adult
;
Bone Neoplasms
;
Congenital Abnormalities
;
Diagnosis
;
Estrogens, Conjugated (USP)
;
Female
;
Fibrous Dysplasia of Bone
;
Fibrous Dysplasia, Polyostotic*
;
Frontal Bone
;
Frontal Sinus
;
Headache
;
Humans
;
Mass Screening
;
Nasal Septum
;
Neurosurgery
;
Orbit
;
Otolaryngology
;
Physicians, Family
;
Primary Health Care*
;
Radionuclide Imaging
;
Watchful Waiting
;
Young Adult
8.Midfacial degloving approach for management of the maxillary fibrous dysplasia: a case report
Miju KANG ; Yu Jin JEE ; Deok Won LEE ; Sang Pil JUNG ; Se Won KIM ; Sunin YANG ; Dong Mok RYU
Maxillofacial Plastic and Reconstructive Surgery 2018;40(1):38-
BACKGROUND: Fibrous dysplasia (FD) is a benign bone lesion characterized by the progressive replacement of normal bone with fibro-osseous connective tissue. The maxilla is the most commonly affected area of facial bone, resulting in facial asymmetry and functional disorders. Surgery is an effective management option and involves removing the diseased bone via an intraoral approach: conservative bone shaving or radical excision and reconstruction. CASE PRESENTATION: This case report describes a monostotic fibrous dysplasia in which the patient’s right midface had a prominent appearance. The asymmetric maxillary area was surgically recontoured via the midfacial degloving approach under general anesthesia. Follow-up photography and radiographic imaging after surgery showed the structures were in a stable state without recurrence of the FD lesion. Furthermore, there were no visible scars or functional disability, and the patient reported no postoperative discomfort. CONCLUSIONS: In conclusion, the midfacial degloving approach for treatment of maxillary fibrous dysplasia is a reliable and successful treatment option. Without visible scars and virtually free of postoperative functional disability, this approach offers good exposure of the middle third of the face for treatment of maxillary fibrous dysplasia with excellent cosmetic outcomes.
Anesthesia, General
;
Cicatrix
;
Connective Tissue
;
Facial Asymmetry
;
Facial Bones
;
Fibrous Dysplasia, Monostotic
;
Follow-Up Studies
;
Humans
;
Maxilla
;
Photography
;
Recurrence
9.Secondary Aneurysmal Bone Cyst in a Craniofacial Fibrous Dysplasia: Case Report.
Hyun Seok LEE ; Young Cho KOH ; Hong Gee ROH ; Hyung Kyu PARK ; Soo Yeon KIM
Brain Tumor Research and Treatment 2018;6(2):86-91
Aneurysmal bone cyst (ABC) is a rare non-neoplastic bone lesion that involves mostly the long bones and vertebrae and may occur very rarely in the craniofacial bones. ABCs may occur as secondary bony pathologies in association with various benign and malignant bone tumors and with fibrous dysplasia (FD). FD is a common non-neoplastic bony pathology mostly affecting craniofacial bones. Secondary ABC occurring in craniofacial FD is extremely rare, with only approximately 20 cases reported in the literature to date. Here, we report on a case of secondary ABC in a 25-year-old woman who has had a craniofacial deformity for over 10 years and who presented to us with a rapidly growing painful pulsatile mass in the right frontal region that began over 2 months prior to admission. On thorough examination of computed tomography and magnetic resonance imaging brain scans taken at two-month interval, an aggressive, rapidly enlarging ABC, arising from the right frontal FD, was diagnosed. The patient underwent preoperative embolization followed by gross total resection of the ABC and cranioplasty. The 6-month follow up showed no recurrence of the ABC, nor was any progression of the FD noticed.
Adult
;
Aneurysm*
;
Bone Cysts*
;
Bone Cysts, Aneurysmal
;
Brain
;
Congenital Abnormalities
;
Craniotomy
;
Female
;
Fibrous Dysplasia of Bone
;
Follow-Up Studies
;
Frontal Bone
;
Humans
;
Magnetic Resonance Imaging
;
Pathology
;
Recurrence
;
Spine
10.Fibrous Dysplasia in the Epiphysis of the Distal Femur
The Journal of Korean Knee Society 2017;29(1):69-71
Fibrous dysplasia is a common benign skeletal lesion that may involve a single bone or multiple bones. Although fibrous dysplasia can affect any bone, monostotic fibrous dysplasia of the long bone typically occurs in the diaphysis or metaphysis. We report a very rare case of monostotic fibrous dysplasia involving the epiphysis of the distal femur in a young man.
Diaphyses
;
Epiphyses
;
Femur
;
Fibrous Dysplasia, Monostotic

Result Analysis
Print
Save
E-mail